Meeting
2020 Gastrointestinal Cancers Symposium
Is adjuvant chemotherapy beneficial for stage II-III goblet cell tumors of the appendix?
Authors
Katerina Mary Zakka
Winship Cancer Institute of Emory University, Atlanta, GA
Katerina Mary Zakka , Shayla Williamson , Renjian Jiang , Olatunji B. Alese , Walid Labib Shaib , Christina Wu , Madhusmita Behera , Bassel F. El-Rayes , Mehmet Akce
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Hepatobiliary Cancer, Neuroendocrine/Carcinoid, Pancreatic Cancer, and Small Bowel Cancer
Track
Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Pancreatic Cancer,Small Bowel Cancer,Other GI Cancer
Sub Track
Therapeutics
Citation
J Clin Oncol 38, 2020 (suppl 4; abstr 796)
Abstract #
796
Poster Bd #
P2
Abstract Disclosures
Similar Posters
Poster
2013 Gastrointestinal Cancers Symposium
Association of time to adjuvant chemotherapy (TTAC) and overall survival among patients with rectal cancer treated with preoperative radiation.
First Author: Gillian Gresham
Poster
2020 Gastrointestinal Cancers Symposium
The influence of adjuvant chemotherapy dose intensity on overall survival in resected colon cancer: A multicenter retrospective analysis.
First Author: Suganija Lakkunarajah
Poster
2018 Gastrointestinal Cancers Symposium
Early survival outcomes in stage I-III operated colon cancer patients from a low prevalence, lower-middle income country: The Indian experience.
First Author: Rushabh Kiran Kothari
Poster
2015 Genitourinary Cancers Symposium
Management and outcomes of clinical stage II a/b seminoma: Results from the National Cancer Database.
First Author: Jonathan J. Paly